Advertisement The final analysis included two propensity scorematched cohorts of 4,212 patients each: one receiving a GLP-1 receptor agonist or GLP-1/GIP dual agonist and one not receiving these therapies
Statements Author contributions EC: Validation, Formal analysis, Writing original draft, Methodology, Supervision, Data curation, Project administration, Writing review & editing, Investigation, Visualization, Software, Conceptualization, Funding acquisition, Resources
Hence, for some patients, anti-oxidant tablets can be helpful to fight skin pigmentation
Many patients report reduced appetite and feeling satisfied with smaller portions within the first few days of starting GLP-1 therapy